SFA Therapeutics is a clinical stage start-up biotech company developing compounds discovered in human microbiome. This patented and proprietary platform is based on immuno-modulation of inflammatory factors derived from human gut microbiome. The technology is licensed from and supported by research at Temple University in Philadelphia. These products are a unique native immunotherapy platform with activity currently being investigated in cancer, liver, and auto-immune disease.
Location: United States, Pennsylvania, Philadelphia
Employees: 1-10
Total raised: $4M
Investors 8
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.06.2022 | - | $4M | - |
Mentions in press and media 22
| Date | Title | Description |
| 17.10.2022 | Dr. Daniel Sauder joins the SFA Therapeutics Scientific Advisory Board | Daniel Sauder, MD An experienced Key Opinion Leader in Dermatology, Dr. Sauder will add significant input to the dermatology development program at SFA Therapeutics I am most enthusiastic about working with the talented team at SFA. Their m... |
| 20.06.2022 | SFA THERAPEUTICS, INC. CLOSES SEED ROUND RAISE of $4M | Treating the root cause of autoimmune disease™ Funds are focused on Phase 1b clinical trial in psoriasis SFA Therapeutics wishes to thank our lead investors for the confidence that they have shown in our new approach to the treatment of aut... |
| 24.01.2022 | Ben Franklin Approved $2.4M in 12 Early Stage Companies | |
| 06.01.2022 | Pismo Ventures' National Venture Plan Startup Competition Announces Winners | National Startup Competition by Pismo Ventures - Winners Announced “For the second year in a row, we were able to provide a truly unique experience for startup businesses within different industries while providing them access and exposure ... |
| 01.09.2021 | Here are all the companies from Day 2 of Y Combinator’s Summer 2021 Demo Day | Welcome back to TechCrunch’s continuing coverage of Y Combinator’s Summer 2021 Demo Day! This is Day Two. If you haven’t caught up yet on what happened during the first day, you can read our recap of all the presenting companies here, our f... |
| 24.08.2021 | Y Combinator startup Lumify Care, cofounded by a Penn grad, is the accelerator’s first nurse-led team | Like many 2021 graduates, University of Pennsylvania alum Anthony Scarpone-Lambert knew he’d be entering a pandemic-tinged workforce. For former nursing students like him, their real-world experience has been wholly consumed by the coronavi... |
| 12.07.2021 | These Philly startups were accepted into Y Combinator’s summer 2021 cohort | Two Philadelphia-based startups are participating in the prominent Silicon Valley accelerator Y Combinator this summer for its second summer of virtual sessions running from June through August. Therapeutics company SFA Therapeutics, Inc. a... |
| 13.05.2021 | To expand or not to expand? Houston researcher weighs in on global growth | You built your business from the ground up, patiently finding techniques and products that work, carefully crafting solid bonds with your clients. Then one day a new project, opportunity or simple request poses a question: Is it time to bra... |
| 11.05.2021 | Global accelerator announces 5 startups to its Houston cohort | Five Houston companies have been tapped to participate in a Houston-based, early-stage startup accelerator with a national presence. The accelerator, gBETA, selected the five Houston companies out of over 85 applicants. The cohort represent... |
| 10.05.2021 | Energy giant makes Houston sole headquarters in massive move | Power player NRG Energy is laser focused on Houston. The Bayou City will be the energy giant's new sole headquarters; the company will no longer split between Houston and Princeton, New Jersey. The move to a single headquarters simplifies b... |
Show more